News
May 9, 2022
FOR IMMEDIATE RELEASE
May 9, 2022
Intrinsica Announces RAPID Alliance 2.0 Launch Event and Innovation Acceleration Forum for Solving $528 Billion Dollar Medications Use Challenge
LOUISVILLE, Kentucky. Today, Intrinsica Inc., a non-profit organization, announced the dates for the RAPID Alliance 2.0 Launch Meeting and Innovation Acceleration Forum for solving a $528 billion dollar medications use challenge affecting 200 million or more people in the US. The event is occurring on June 21 and 22, 2022, virtually.
The event is designed to bring together a select group of leaders, scholars, innovators, funders, technologists, government leaders and others from across the US medications sector, including all key professions, to share, fund and implement transformational innovations with potential to solve this challenge.
Of the event, Intrinsica Co-Founder and Chief Science Officer, Dr. Judah Thornewill, said "we are excited to be taking this next step to address this difficult challenge. At the event, we are also pleased to be using the first version of Intrinsica Accelerate,™ our research-driven platform for accelerating innovation at ecosystem scales.
The agenda includes information about plans to raise up to $25M in 2022, and $5 billion or more (cumulative) over the next decade, to support hundreds of public and private sector innovations to help solve this problem.
To sign-up, please visit spring2022.intrinsica.org.
About Intrinsica and the RAPID Alliance. Intrinsica, Inc. is a non-profit organized to accelerate innovation to solve some of societies most difficult challenges. The RAPID Alliance is Intrinsica's first innovation network, organized to solve a $528 billion medication and vaccine use challenge in the US, expanding globally.
